These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 81299)

  • 21. Kinetics of drug-drug interactions in sheep: tolbutamide and sulfadimethoxine.
    Thiessen JJ; Rowland M
    J Pharm Sci; 1977 Aug; 66(8):1063-70. PubMed ID: 894490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative pharmacokinetics of coumarin anticoaglulants XLI: Effect of phenobarbital on systemic availability of orally administered dicumarol in rats.
    Crow JW; Gibaldi M; Levy G
    J Pharm Sci; 1979 Aug; 68(8):958-62. PubMed ID: 90143
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug interaction in anaesthesia. A review.
    Ghoneim MM
    Can Anaesth Soc J; 1971 Jul; 18(4):353-75. PubMed ID: 4109886
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of serum protein binding on pharmacokinetics and anticoagulant activity of phenprocoumon in rats.
    Trenk D; Jähnchen E
    J Pharmacokinet Biopharm; 1980 Apr; 8(2):177-91. PubMed ID: 7431221
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetic analysis of the interaction between dicoumarol and tolbutamide in man.
    Jähnchen E; Meinertz T; Gilfrich HJ; Groth U
    Eur J Clin Pharmacol; 1976 Sep; 10(5):349-56. PubMed ID: 61862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of the binding of coumarin anticoagulants and serum albumins.
    Garten S; Wosilait WD
    Biochem Pharmacol; 1971 Jul; 20(7):1661-8. PubMed ID: 4126702
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug interactions involving the displacement of drugs from plasma protein and tissue binding sites.
    D'Arcy PF; McElnay JC
    Pharmacol Ther; 1982; 17(2):211-20. PubMed ID: 6757977
    [No Abstract]   [Full Text] [Related]  

  • 28. Relationship between dicumarol distribution and the effect of enzyme induction on dicumarol elimination in rats.
    Lai CM; Yacobi A; Levy G
    J Pharmacol Exp Ther; 1976 Oct; 199(1):74-81. PubMed ID: 62050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between distribution, elimination and anticoagulant action of dicumarol.
    Jähnchen E; Levy G
    J Pharmacol Exp Ther; 1974 Feb; 188(2):293-9. PubMed ID: 4129954
    [No Abstract]   [Full Text] [Related]  

  • 30. Multiple competitive displacement interactions involving human serum albumin, anticoagulants, oleic acid and various drugs.
    Wosilait WD; Ryan MP
    Gen Pharmacol; 1980; 11(4):387-94. PubMed ID: 6156878
    [No Abstract]   [Full Text] [Related]  

  • 31. [Influence of tolbutamide on the binding capacity of serum protenns for I-131 thyroxine, I-131 insulin and cortisol].
    Schemmel K; Lahrtz H; Leybold K; Haupt E; Eickenbusch W
    Verh Dtsch Ges Inn Med; 1969; 75():782-5. PubMed ID: 5401637
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on 8-methoxypsoralen tolbutamide interactions. 2. Studies after U.V.-A irradiation in vitro and in vivo.
    Bevilacqua R; Baccichetti F
    Farmaco; 1991 Dec; 46(12):1449-57. PubMed ID: 1821629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of graphical and computerized methods for calculating binding parameters for two strongly bound drugs to human serum albumin.
    Vallner JJ; Perrin JH; Wold S
    J Pharm Sci; 1976 Aug; 65(8):1182-7. PubMed ID: 62049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of blood sampling schedules on protein drug binding in the rat.
    Hulse M; Feldman S; Bruckner JV
    J Pharmacol Exp Ther; 1981 Aug; 218(2):416-20. PubMed ID: 6166741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of drug metabolism by chloramphenicol.
    Christensen LK; Skovsted L
    Lancet; 1969 Dec; 2(7635):1397-9. PubMed ID: 4188280
    [No Abstract]   [Full Text] [Related]  

  • 36. Impairment by cholestyramine of dicumarol and tromexan absorption in rats: a potential drug interaction.
    Tembo AV; Bates TR
    J Pharmacol Exp Ther; 1974 Oct; 191(1):53-9. PubMed ID: 4138553
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug interactions in cardiovascular therapy].
    Koch-Weser J
    Schweiz Med Wochenschr; 1976 Nov; 106(45):1531-8. PubMed ID: 65008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative pharmacokinetics of coumarin anticoagulants. IV. Application of a three-compartmental model to the analysis of the dose-dependent kinetics of bishydroxycoumarin elimination.
    Nagashima R; Levy G; O'Reilly RA
    J Pharm Sci; 1968 Nov; 57(11):1888-95. PubMed ID: 4177836
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of protein binding on the pharmacokinetics of sulfanilamides in rats].
    Funk KF
    Acta Biol Med Ger; 1971; 27(3):611-7. PubMed ID: 5147704
    [No Abstract]   [Full Text] [Related]  

  • 40. An immunologic approach to the understanding of the physiologic disposition.
    Weiner M
    Life Sci; 1973 Dec; 13(11):1473-81. PubMed ID: 4129292
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.